Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Army
Johnson and Johnson
Chubb
QuintilesIMS
McKesson
Dow
Deloitte
Federal Trade Commission

Generated: December 13, 2018

DrugPatentWatch Database Preview

TIMOLOL MALEATE Drug Profile

« Back to Dashboard

When do Timolol Maleate patents expire, and when can generic versions of Timolol Maleate launch?

Timolol Maleate is a drug marketed by Sandoz Inc, Akorn, Apotex Inc, Bausch And Lomb, Fdc Ltd, Fougera, Hi Tech Pharma, Pacific Pharma, Wockhardt, Mylan, Quantum Pharmics, Teva, Usl Pharma, Watson Labs, and Yaopharma Co Ltd. and is included in thirty-eight NDAs. There is one patent protecting this drug.

This drug has twenty-one patent family members in eighteen countries.

The generic ingredient in TIMOLOL MALEATE is timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the timolol maleate profile page.

Drug patent expirations by year for TIMOLOL MALEATE
Pharmacology for TIMOLOL MALEATE
Synonyms for TIMOLOL MALEATE
(-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate
(-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate (1:1) (salt)
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(-)-Timolol
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol
(2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol (2Z)-but-2-enedioate
(2S)-1-(TERT-BUTYLAMINO)-3-{[4-(MORPHOLIN-4-YL)-1,2,5-THIADIAZOL-3-YL]OXY}PROPAN-2-OL; MALEIC ACID
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol (2Z)-2-Butenedioate Salt
(2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol
(2Z)-but-2-enedioic acid; tert-butyl[(2S)-2-hydroxy-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl]amine
(S)-(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole Hydrogen Maleate
(S)-(-)-Timolol Maleate
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol maleate
(S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol
(S)-3-(3-(tert-bUtylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole maleate
(S)-3-(3-(tert-Butylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole monomaleate
(S)-timolol
(S)-timolol (anhydrous)
(S)-Timolol (Maleate)
(S)-Timolol hydrogen maleate
(S)-Timolol maleate
(Z)-but-2-enedioic acid; (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(Z)-but-2-enedioic acid;(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
1-( tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate
1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol
131628-37-0
194288-09-0
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-
2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-, (Z)-2-butenedioate (1:1) (salt)
2-Propanol, 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-, (-)-, maleate (1:1) (salt)
2-Propanol, 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-, (-)-,maleate (1:1) (salt)
2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-
2-Propanol,1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-,(2S)-
26839-75-8
26839-75-8 (Parent)
26921-17-5
26921-17-5 (maleate (1:1) salt)
30166-36-0
3B1-003748
5JKY92S7BR
60469-65-0
839T758
921T175
AB0021275
AB00513729
AB00513729-17
AC1L1PYN
AC1NQXYE
AC1Q59QM
AKOS015969764
AKOS024458595
API0004422
Apo-Timol
Apo-Timol (TN)
Apo-Timop
Apo-Timop (TN)
Aquanil
ARONIS24479
arutimol
AS-18090
BBC/645
BDBM50292219
Betim
Betime
Betimol
Betimol (TN)
BG0340
BIDD:GT0073
Bimatoprost / timolol
Bio-0875
BLJRIMJGRPQVNF-JTQLQIEISA-N
Blocadren
Blocadren (TN)
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
C-19486
C07141
C13H24N4O3S.C4H4O4
CAS-26839-75-8
CAS-26921-17-5
CC-35068
CCG-220948
CCRIS 1057
CHEBI:9599
CHEBI:9600
CHEMBL1200870
CHEMBL499
CPD000653470
CS-1028
CTK4F8602
D00603
D05UVD
D08600
DB00373
DSSTox_CID_27504
DSSTox_CID_3674
DSSTox_GSID_23674
DSSTox_GSID_47504
DSSTox_RID_77140
DSSTox_RID_82384
DTXSID3047504
DTXSID4023674
EINECS 248-032-6
EINECS 248-111-5
EINECS 262-251-4
FT-0082529
FT-0630529
Gen-Timolol (TN)
GTPL565
HE061310
HE068325
HE330337
HMS1570N18
HMS2089I11
HMS2097N18
HMS2230N19
HMS2234F03
HMS3259C20
HSDB 6533
HY-17380
Istalol
Istalol (TN)
KB-61736
L-714,465
L-Timolol
l-Timolol maleate
Lopac-T-6394
Lopac0_001189
LS-121851
LS-122231
MFCD00058356
MK 950
MK-950
MLS000028539
MLS001076135
MolPort-002-545-241
MolPort-006-125-123
NC00592
NCGC00016038-01
NCGC00016038-02
NCGC00016798-01
NCGC00016798-02
NCGC00016798-03
NCGC00016798-05
NCGC00016798-06
NCGC00016798-07
NCGC00016798-08
NCGC00016798-09
NCGC00016798-11
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
NCGC00256737-01
Novo-Timol
Nu-Timolol
Nu-Timolol (TN)
Opera_ID_1256
Oprea1_640981
Optimol
P8Y54F701R
Phoxal-timolol
Phoxal-timolol (TN)
PMS-Timolol (TN)
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
Q-201836
S-(-)-1-(t-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate salt
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
S(-)-Timolol maleate
s4123
SAM002564238
SCHEMBL26233
SCHEMBL4912
SMR000058305
SMR000653470
SPBio_003075
ST072193
Temserin
Tenopt
TIM
Tim-AK
Tim-AK (TN)
Timacar
Timacor
timolol
Timolol (INN)
Timolol (TN)
Timolol [USAN:INN]
Timolol [USAN]
Timolol anhydrous
Timolol for system suitability, European Pharmacopoeia (EP) Reference Standard
Timolol GFS
Timolol hydrogen maleate
Timolol hydrogenmaleate
Timolol maleate (JP17/USP)
Timolol maleate [USAN:JAN]
Timolol maleate [USAN:USP:JAN]
Timolol Maleate 1.0 mg/ml in Methanol (as free base)
Timolol maleate salt
Timolol maleate salt, >=98% (TLC), powder
Timolol Maleate, (1:1) Salt
Timolol maleate, British Pharmacopoeia (BP) Reference Standard
Timolol maleate, European Pharmacopoeia (EP) Reference Standard
Timolol maleate, United States Pharmacopeia (USP) Reference Standard
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic (TN)
Timoptic in Ocudose
Timoptic OcuDose
Timoptic OcuDose. (TN)
Timoptic-XE
Timoptic-XE (TN)
Timoptic?XE
Timoptol
Tocris-0649
Tox21_110614
Tox21_110614_1
Tox21_302468
UNII-5JKY92S7BR
UNII-P8Y54F701R
W-107148
W0079
WLRMANUAADYWEA-NWASOUNVSA-N
ZINC2176

US Patents and Regulatory Information for TIMOLOL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yaopharma Co Ltd TIMOLOL MALEATE timolol maleate TABLET;ORAL 072550-001 Apr 13, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Usl Pharma TIMOLOL MALEATE timolol maleate TABLET;ORAL 072001-001 Apr 11, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Quantum Pharmics TIMOLOL MALEATE timolol maleate TABLET;ORAL 072468-001 May 19, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Usl Pharma TIMOLOL MALEATE timolol maleate TABLET;ORAL 072002-001 Apr 11, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva TIMOLOL MALEATE timolol maleate TABLET;ORAL 072648-001 Jun 16, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for TIMOLOL MALEATE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/1999 Austria ➤ Try a Free Trial PRODUCT NAME: DORZOLAMID ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE DORZOLAMIDHYDROCHLORID, UND TIMOLOL ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE TIMOLOLMALEAT; NAT. REGISTRATION NO/DATE: 1-22701, 1-22702 19980828; FIRST REGISTRATION: DK 9794 19980306
90041 Netherlands ➤ Try a Free Trial PRODUCT NAME: DORZOLAMIDE, DESGEWENST IN DE VORM VAN EEN OFTALMOLOGISCH AAN- VAARDBAAR ZOUT, EN TIMOLOL, DESGEWENST IN DE VORM VAN EEN OFTAL -MOLOGISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER DORZOLLAMIDEHY- DROCHLORIDE EN TIMOLOLMALEAAT, EEN EN ANDER ZODANIG DAT 0,05; NATL REGISTRATION NO/DATE: VG 22871 19980805; FIRST REGISTRATION: DK 19045 19980306
00C/001 Belgium ➤ Try a Free Trial PRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306
C/GB99/043 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804
C0013 Belgium ➤ Try a Free Trial PRODUCT NAME: TIMOLOLI MALEAS EQ. TIMOLOLUM; NATIONAL REGISTRATION/DATE: 922 IS 166 F 13 19950627; FIRST REGISTRATION: SE 11901 19930910
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Fuji
Covington
Citi
McKinsey
US Army
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.